IMR Press / RCM / Volume 22 / Issue 1 / DOI: 10.31083/j.rcm.2021.01.802
Open Access Original Research
Accuracy and feasibility of portable blood pressure monitoring in the detection of atrial fibrillation in hemodialysis patients
Show Less
1 School of medicine, University of Jordan, 11942 Amman, Jordan
2 Islamic and Al-Essra Hospitals, 11181 Amman, Jordan
3 University of Jordan, 11942 Amman, Jordan
4 Hackensack Meridian Health Palisades Medical Center, North Bergen, 07047 NJ, USA
Rev. Cardiovasc. Med. 2021 , 22(1), 225–229;
Submitted: 28 January 2021 | Revised: 19 March 2021 | Accepted: 22 March 2021 | Published: 30 March 2021

Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in clinical practice and is a common comorbidity in hemodialysis patients. AF contributes to cardiovascular complications; therefore, it is recommended to screen for AF in high-risk patients to prevent serious complications. As we currently lack a handy AF screening tool, the aim of this study was to assess the accuracy of a modified BP monitor (Omron M6), in detecting AF in hemodialysis patients. In a cross-sectional analysis conducted from October 2018 to February 2019, we enrolled all the hemodialysis patients, older than 18 years and maintained on hemodialysis for at least 3 months in four hemodialysis centers in Jordan. Logistic regression was used to predict the accuracy, while the R package (epiR) was used to determine the sensitivity and specificity of the Omron M6 in screening AF. A total of 227 patients participated in the study, with a median age of 57 years (42.8-67.3); among these, 44.5% were female. Of all the participants, 18 were detected with AF, which was confirmed by a 12-lead ECG. The prevalence of AF in our study was 7.9%, while the sensitivity, specificity and accuracy of the Omron M6 in detecting AF were calculated as 83.0% (95% CI, 59.0-96.0), 94.0% (95% CI, 90.0-97.0) and 93.4% (95% CI, 88.0-95.0) respectively. We concluded that Omron M6 has high sensitivity, specificity, and accuracy in screening AF among hemodialysis patients. However, further studies are required to ascertain and firmly establish this preliminary finding.

Atrial fibrillation
Blood pressure monitor
Back to top